Tectonic Therapeutic | AVRO - Debt


Tectonic Therapeutic reported $876K in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alnylam Pharmaceuticals USD 1.31B 11.39M Sep/2025
Celltrion KRW 171.09B 2.05T Jun/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Karyopharm Therapeutics USD 264.09M 39.31M Sep/2024
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
MacroGenics USD 37.01M 238K Sep/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 60.85B 78M Sep/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 21.76B 530M Sep/2025
Sarepta Therapeutics USD 1.25B 103.69M Sep/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Takeda JPY 4.85T 208B Dec/2025
Tilray USD 640.95M 35.17M Jun/2022
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025